BioGaia AB, commonly referred to as BioGaia, is a leading biotechnology company headquartered in Sweden. Founded in 1990, the company has established itself as a pioneer in the development of probiotic products, focusing on gut health and overall well-being. With a strong presence in Europe, North America, and Asia, BioGaia operates within the health and wellness industry, specifically in the probiotics sector. The company’s core offerings include a range of probiotic supplements and functional foods, distinguished by their unique strains of Lactobacillus reuteri. BioGaia's commitment to scientific research and innovation has led to numerous key milestones, including partnerships with major global brands and a robust portfolio of clinical studies supporting their products. Recognised for its market leadership, BioGaia continues to enhance its reputation through ongoing advancements in probiotic technology and consumer education.
How does Biogaia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biogaia's score of 59 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, BioGaia AB reported total greenhouse gas emissions of approximately 7,300,000 kg CO2e, with emissions distributed across Scope 1, Scope 2, and Scope 3. Specifically, Scope 1 emissions were about 73,000 kg CO2e, while Scope 2 emissions totalled approximately 33,000 kg CO2e. The majority of emissions stemmed from Scope 3, which accounted for about 7,168,000 kg CO2e, primarily from downstream transportation and distribution, contributing approximately 4,592,000 kg CO2e. Comparatively, in 2023, BioGaia's emissions were slightly lower, with total emissions of about 6,284,000 kg CO2e, including 77,000 kg CO2e from Scope 1 and 32,000 kg CO2e from Scope 2. The company has demonstrated a commitment to reducing its emissions, setting a target to decrease Scope 1 and Scope 2 emissions by 46% by 2030 from 2019 levels, as validated by the Science Based Targets initiative (SBTi). This target aligns with the goal of limiting global warming to 1.5°C. BioGaia has also committed to achieving near-zero emissions for both Scope 1 and Scope 2 by 2050, reflecting a long-term strategy to mitigate its carbon footprint. The company’s emissions data is sourced directly from BioGaia AB (publ) and does not cascade from any parent organization.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 7,000 | 0,000 | - | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 2 | 61,000 | 00,000 | 00,000 | 0,000 | 00,000 | 00,000 | 00,000 |
| Scope 3 | 2,438,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Biogaia's Scope 3 emissions, which increased by 14% last year and increased by approximately 194% since 2018, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the primary emissions source at 64% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biogaia has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
